📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Reducing dynamin 2 (DNM2) rescues DNM2-related dominant centronuclear myopathy. (2018)

First Author: Buono S

Attributed to: Determining how mutations in actin lead to skeletal muscle weakness funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1808170115

PubMed Identifier: 30291191

Publication URI: http://europepmc.org/abstract/MED/30291191

Type: Journal Article/Review

Volume: 115

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 43

ISSN: 0027-8424